06185 CANSINOBIO
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.42X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 22.6% | Net Margin | N/A |
Total Debt/Equity | 41.0% | Return on Equity | N/A |
Price/Book | 1.82X | Return on Assets | N/A |
(HKD 38.450) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -402.94 | -1,634.27 | -1,019.65 | 2,341.49 | -470.73 |
---|---|---|---|---|---|
Net Profit Growth (%) | +75.3 | -60.3 | -143.6 | +597.4 | -168.6 |
Earnings Per Share (HKD) | -1.632 | -6.623 | -4.128 | 9.463 | -2.039 |
Earnings Per Share Growth (%) | +75.4 | -60.4 | -143.6 | +564.2 | -136.4 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | 0.937 | No dividend |
P/E* (X) | N/A | N/A | N/A | 4.06 | N/A |
Yield (%) | N/A | N/A | N/A | 2.44 | N/A |
Dividend Share (%) | N/A | N/A | N/A | 9.91 | N/A |
Book NAV (HKD) | 21.137 | 23.494 | 30.576 | 39.518 | 29.117 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 824.884 | 345.182 | +139.0 | 1,031 |
Operating Result | -294.684 | -1,980 | -85.1 | -1,184 |
Associates | -16.768 | 1.217 | -1,477.8 | 0 |
Profit Before Taxation | -381.204 | -1,979 | -80.7 | -1,184 |
Taxation | 2.467 | -11.451 | -121.5 | -219.244 |
Profit /( Loss) After Taxation | -383.671 | -1,967 | -80.5 | -964.757 |
Minority Interests | -4.787 | -484.701 | -99.0 | -55.326 |
Net Profit | -378.884 | -1,483 | -74.5 | -909.431 |
Earnings Per Share () | -1.6323 | -6.6227 | -75.4 | -4.1278 |
Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
Announcement Date | 2025-03-25 | 2024-03-27 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25